Recommended Conferences for Dermatitis
Dermatitis
Dermatitis simply means skin inflammation, but it embraces a range of ailments. In most people, the early stages of dermatitis are characterized by red, dry, and itchy skin. More serious dermatitis may result in crusty scales or blisters that ooze fluid. Since many things can irritate the skin, a doctor will try to narrow the
diagnosis to a specific category of dermatitis, even though
treatment is similar for most types of skin irritation and inflammation. The term eczema is also commonly used to describe dermatitis. The term eczema is broadly applied to a range of persistent skin conditions. These include dryness and recurring skin rashes that are characterized by one or more of these symptoms: redness, skin swelling, itching and dryness, crusting, flaking, blistering, cracking, oozing, or bleeding. Areas of temporary skin discoloration may appear and are sometimes due to healed injuries. Scratching open a healing lesion may result in scarring and may enlarge the rash. Treatment is typically with moisturizers and steroid creams. If these are not effective, creams based on calcineurin inhibitors may be used. The disease was estimated as of 2010 to affect 230 million people globally (3.5% of the population)
Scope and Importance
Disorders of the skin, hair, and nails fall within the remit of a dermatologist. The specialty is divided broadly into medical and surgical fields, with clinicians in secondary care often practising both. It should be noted that in some countries, training and practice in dermatology are combined with venerology. Dermatology is chiefly an outpatient specialty, and most patient referrals request an initial diagnosis and treatment of an unknown skin disease or review of more complex and chronic cases beyond the skill of the general practitioner. Many developing countries have no skin care specialists and referral is made difficult by distances and availability of travel funds. For example, South Africa has a ratio of 3 to 4 million people per dermatologist, who are usually located in urban areas. 21-87% of the population may be affected by some type of skin problem. Primary care providers are often unable to diagnose and treat skin disease; the economic burden of skin disease in the United States is large: approximately $35.9 billion.
The field of dermatitis has gained remarkable interest all over the world. The major advantage of recent years is the high scientific levels of the most significant new developments in techniques and pharmacotherapy and other nonsurgical approaches like Laser resurfacing, Sclerotherapy, Soft tissue augmentation. With an aging population and increasing consumer awareness, demand for high-quality, innovative cosmeceutical products will be on the rise in 2014.
This study introduces the readers to most skin disorders, and some common procedures. However, as regards analysis, this study limits itself to prescription and therapeutic drugs for dermatological disorders. Cosmetic and aesthetic procedures, aging disorders, and wound care. BCC’s goal in conducting this study was to understand the current status of the US dermatological therapeutics industry and to assess it in the medium term from 2008 through 2013. We were particularly interested in understanding the future market potential for the current and emerging technologies and products within the dermatological therapeutics industry. This report assesses the available therapeutic procedures for skin, along with the drugs and technologies currently being used for various skin treatments. The role of public agencies, the regulatory environment, and non-governmental stakeholders has also been examined.
Market Value:
The dermatitis therapeutic sales in the nine major markets the US, France Germany, Italy, Spain, UK, Japan, China and India — are forecast to increase from $3.9 billion in 2012 to $5.6 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 3.8%. According to the company’s latest report, the anticipated launch of new drugs by Sanofi/Regeneron and Anacor in the mid-term of the forecast period will bring a major boost to the market. Japan will also play a key role in driving global sales, while emerging markets India and China will experience rapid uptake of topical calcineurin inhibitors. With an estimated drug-treated population that hovers around the 54 million mark over the next decade, opportunities will remain in this chronic dermatology disease for other drug developers with novel systemic therapies.
OMICS International Organizes 1000+
Global Events Every Year across USA, Europe & Asia with support from 1000 more
scientific societies Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The
conference series website will provide you list and details about the conference organize worldwide.
1) Allergy Conference
March 29-30, 2016, Valencia, Spain
2) Clinical Case Reports Meeting
April 18-20, 2016, Dubai, UAE
3) Cosmetology, Trichology & Aesthetic Practices Conference
April 25-27, 2016, Dubai, UAE
4) 6th Dermatology Conference
May 05-07, 2016, Chicago, USA
5) Dermatology Meeting
June 13-15, 2016, Alicante, Spain
6) 4th Acupuncture And Therapists Meeting
July 14-16, 2016, Philadelphia, USA
7) 2nd Optometrist And Laser Technology Meeting
July 28-29, 2016, Berlin, Germany
8) 6th Healthcare & Fitness Summit
August 22-24, 2016, Philadelphia, USA
9) 5th Pediatric Congress
Aug 25-27, 2016, Sao Paulo, Brazil
10) Dermatology Congress
September 07-09, 2016, Sao Paulo, Brazil
11) 3rd Biomedical Engineering Conference
September 22-23, 2016, Vienna, Austria
12) Pediatric Dermatology Conference
October 10-12, 2016, Manchester, UK
13) 2nd Telemedicine & EHealth Summit
October 31-November 2, 2016, Istanbul, Turkey
14) 11th Dermatologists Meeting
November 14-16, 2016, Dubai, UAE
15) 2nd Cosmetic Dermatology & Haircare Conference
December 05-06, 2016, Philadelphia, USA
16) Skin Disease Education Foundation's 14th Annual Hawaii Dermatology Seminar, 1st to 6th March, 2015 at Kauai, Hawaii, USA.
17) Dermatology for Primary Care , 22nd to 26th June 2015 at Sarasota, FL, United States of America
18) Family Medicine: Dermatology Review 2015, during May 11-21, 2015 at Celebrity Cruises` Equinox, Barcelona, Spain
19) Dermatology for the PCP 2015 during Jan 31 - Feb 6, 2015 at Royal Caribbean`s Oasis of the Seas, Fort Lauderdale, FL, United States
20) Oral Dermatology and Pathology 2015, June 14-21, 2015 at Celebrity`s Infinity, Vancouver, Canada
Associations and Societies
1) American Academy of Dermatology
2) American Society of Dermatology
3) The American Society of Dermatopathology
4) The American College of Mohs Surgery
5) Women’s Dermatologic Society (WDS)
6) British Association of Dermatologists
7) European Academy of Dermatology & Venerology
8) International Society of Dermatology
9) European Society for Dermatological Research
10) American Board of Dermatology
11) American College of Mohs Surgeons
12) American Dermatological Association, Inc.
13) American Contact Dermatitis Society
14) American Society of Dermatology
15) American Telemedicine Association (ATA) Teledermatology
16) Special Interest Group (SIG)
17) Asian Dermatological Association Ltd
18) Asociación Colombiana de Dermatologia y Cirugía Dermatológica
19) Australasian Society for Dermatology Research
20) Australasian College of Dermatologists
21) British Society of Anti-Ageing Medicine
22) British Society for Dermatological Surgery
23) Canadian Dermatology Foundation
24) Dermatological Society of Malaysia
Major Dermatology and related Companies:
1) Sand Lake Dermatology Center
2) Agabang & Company
3) SkinKind Limited
4) Regeneron Pharmaceuticals, Inc.
5) Dermal Life
6) Dermatology Alliance, Patch Testing Centers of Excellence
7) Dermatology Associates of Concord
8) Galderma
9) Johnson & Johnson
10) AbbVie
11) GSK
12) Pfizer
13) LEO Pharma
14) Apothecus Pharmaceutical Corp
15) Remedi Pharmaceuticals
16) Abgenix, Inc.
17) Abbott Laboratories
18) Acadia Pharmaceuticals
19) Active Pass Pharmaceuticals
20) Advanced Drug Delivery Technologies AG
Related Companies:
1. Agabang & Company
'Excellent SMB' certified by Korea International Trade Association, the biggest business association in Korea.
http://www.putto.kr
2. SkinKind Limited
Specialised in the production and distribution of SkinCare products that treat skin conditions such as Acne, Dermatitis, and Eczema & Psoriasis. They have been dealing with Occupational and Contact Dermatitis for over 20 years, and have recently added the other products ranges.
http://www.skinkind.co.uk
3. Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
http://www.regeneron.com
4. Dermal Life
Dermal Life was founded with a mission to develop advanced skin care products that maximize skin health. Americans spend an estimated $55 billion on skin care annually. Major skin care problems include sunburns, burns, rosacea, dermatitis, chronic wounds, and skin damage caused by age and environmental factors.
http://DermalLife.com 5. Dermatology Alliance, Patch Testing Centers of Excellence
The Dermatology Alliance, Patch Testing Centers of Excellence is exclusively focused on providing exceptional patch testing services.
http://patchtestingcenters.com
6. Dermatology Associates of Concord
The physicans at Dermatology Associates are experts in diseases of the skin, hair and nails. There products take care for all of the common, as well as the chronic, and most of the complicated skin disorders.
This page will be updated regularly.
This page was last updated on November 5, 2024
